Chatsworth Securities is proud to announce our engagement as strategic advisor to Life Biosciences, the company at the forefront of what may become the most transformative scientific breakthrough of the century: the ability to reverse aging at the cellular level.

Under the leadership of Managing Director Alessandro Bianchi, Chatsworth will support Life Biosciences in raising capital for its next phase of development as the company prepares for first-in-human clinical trials in 2026. These trials mark a historic moment — the transition of epigenetic reprogramming from laboratory success to real-world medicine.

Life Biosciences is leveraging OSK, a trio of natural proteins that restore youthful functionality to aged cells by resetting the body’s biological “software.” In preclinical studies, this approach has reversed vision loss, rejuvenated tissues, repaired damaged nerves, and restored youthful gene expression. What was once science fiction is now emerging as a real therapeutic platform capable of addressing some of humanity’s most devastating age-related diseases.

This technology has the potential not just to extend lifespan, but to dramatically enhance healthspan, enabling people to live longer, healthier, more productive lives. Its implications reach far beyond medicine — touching global productivity, healthcare economics, human performance, and the very definition of aging.

At Chatsworth Securities, we have always stood behind innovations that reshape industries. Supporting Life Biosciences represents an opportunity to contribute to a scientific frontier with the potential to change lives on a global scale.

Alessandro Bianchi and the Chatsworth team are honored to help bring this breakthrough to the world by connecting Life Biosciences with visionary investors who recognize the magnitude of this moment.

The future of medicine is no longer about slowing aging — it is about reversing it. What Life Biosciences is building has the potential to transform human health at a global scale, and Chatsworth is proud to stand at the center of this revolution.”
— Alessandro Bianchi, Managing Director, Chatsworth Securities